Elon Musk’s Neuralink neurotechnology startup company received approval from the U.S. Food and Drug Administration (FDA) on Thursday to launch its first in-human clinical study.
Published: Monday, June 12th, 2023 @ 9:15 am
By: Daily Wire
|